Literature DB >> 33706708

Long noncoding RNA CASC7 inhibits the proliferation and migration of papillary thyroid cancer cells by inhibiting miR-34a-5p.

Wencong Sun1,2,3, Detao Yin4,5.   

Abstract

Long noncoding RNAs (lncRNAs) play an essential role in the progression of papillary thyroid cancer (PTC). However, the expression and function of lncRNA cancer susceptibility candidate 7 (CASC7) in PTC remain unknown. The purpose of this study was to investigate the role and molecular mechanism of CASC7 in regulating PTC cell behavior. The expression of CASC7, miR-34a-5p, and tumor protein P73 (TP73) was determined by qRT-PCR and western blot. Cell proliferation was examined by MTT assay. Cell apoptosis was assessed by flow cytometry following Annexin V and PI staining. Cell migration was determined by Transwell migration assay. The interaction between miR-34a-5p and CASC7 or TP73 was examined by luciferase reporter assay. CASC7 and TP73 expression were significantly lower, whereas miR-34a-5p expression was higher in PTC tissues than the adjacent normal tissues. Furthermore, CASC7 overexpression inhibited cell proliferation and migration, whereas facilitated cell apoptosis in human PTC cell lines (K1 and TPC-1). Mechanistically, CASC7 acted as a sponge of miR-34a-5p to upregulate TP73 expression. Moreover, miR-34a-5p mimic transfection could abate the CASC7-regulated PTC cell proliferation, migration, and apoptosis. Collectively, CASC7 inhibited the proliferation and migration of PTC cells by sponging miR-34a-5p to upregulate TP73 expression.

Entities:  

Keywords:  CASC7; TP73; Thyroid cancer; miR-34a-5p

Year:  2021        PMID: 33706708     DOI: 10.1186/s12576-021-00793-2

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  6 in total

1.  The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.

Authors:  X-M Fu; W Guo; N Li; H-Z Liu; J Liu; S-Q Qiu; Q Zhang; L-C Wang; F Li; C-L Li
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-07       Impact factor: 3.507

2.  MicroRNA‑663b mediates TAM resistance in breast cancer by modulating TP73 expression.

Authors:  Hua Jiang; Lin Cheng; Pan Hu; Renbin Liu
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

3.  Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.

Authors:  Cunrong Chen; Lili Zhou; Hui Wang; Junnian Chen; Wen Li; Wei Liu; Mingjie Shen; Hongzhou Liu; Xiaomin Fu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

4.  Long non‑coding RNA MALAT1 sponges miR‑124‑3p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension.

Authors:  Dapeng Wang; Hongyang Xu; Bo Wu; Shuyun Jiang; Hong Pan; Ruilan Wang; Jingyu Chen
Journal:  Int J Mol Med       Date:  2019-06-25       Impact factor: 4.101

5.  Integrated bioinformatics analysis reveals role of the LINC01093/miR-96-5p/ZFAND5/NF-κB signaling axis in hepatocellular carcinoma.

Authors:  Yahui Zheng; Kangkang Yu; Chong Huang; Lu Liu; Hao Zhao; Meisi Huo; Jubo Zhang
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

6.  Incidence of gastrointestinal stromal tumor in Chinese urban population: A national population-based study.

Authors:  Lu Xu; Yanpeng Ma; Shengfeng Wang; Jingnan Feng; Lili Liu; Jinxi Wang; Guozhen Liu; Dianrong Xiu; Wei Fu; Siyan Zhan; Tao Sun; Pei Gao
Journal:  Cancer Med       Date:  2020-12-15       Impact factor: 4.452

  6 in total
  2 in total

Review 1.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

2.  Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis.

Authors:  Genjin Wang; Peng Duan; Feng Liu; Zhengkuo Wei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.